platinum has been researched along with buthionine sulfoximine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hill, BT; Hosking, LK; Shellard, SA | 1 |
Maines, MD; Mayer, RD | 1 |
Himeno, S; Ikeda, K; Imura, N; Miura, K; Naganuma, A | 1 |
Aldrich-Wright, JR; Garbutcheon-Singh, KB; Harper, BW; Myers, S | 1 |
4 other study(ies) available for platinum and buthionine sulfoximine
Article | Year |
---|---|
Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
Topics: Buthionine Sulfoximine; Cisplatin; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Female; Glutathione; Glutathione Transferase; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured | 1991 |
Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
Topics: Animals; Buthionine Sulfoximine; Cytochrome P-450 Enzyme System; Drug Synergism; Glutathione; Heme Oxygenase (Decyclizing); Kidney; Male; Methionine Sulfoximine; Organoplatinum Compounds; Platinum; Porphyrins; Rats; Rats, Inbred Strains; Stereoisomerism; Subcellular Fractions | 1990 |
Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum.
Topics: Animals; Buthionine Sulfoximine; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Glutathione; PC12 Cells; Platinum; Rats; Sensitivity and Specificity; Statistics as Topic; Time Factors | 2001 |
Combination studies of platinum(II)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Carboplatin; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Organoplatinum Compounds; Platinum; Pyruvates | 2014 |